We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-1.09%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$5.03B
AUM Growth
-$413M
Cap. Flow
-$287M
Cap. Flow %
-5.7%
Top 10 Hldgs %
6.08%
Holding
2,696
New
268
Increased
867
Reduced
1,045
Closed
507

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$36.6M
2
COST icon
Costco
COST
+$28.6M
3
AZO icon
AutoZone
AZO
+$27.6M
4
EOG icon
EOG Resources
EOG
+$24.1M
5
LOW icon
Lowe's Companies
LOW
+$22M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$32.4M
2
LYB icon
LyondellBasell Industries
LYB
+$32.2M
3
VEEV icon
Veeva Systems
VEEV
+$29.2M
4
CIEN icon
Ciena
CIEN
+$26.9M
5
PGR icon
Progressive
PGR
+$25M

Sector Composition

Rank Sector Weight
1 Technology 15.28%
2 Consumer Discretionary 13.64%
3 Financials 13.37%
4 Healthcare 12.74%
5 Industrials 12.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHTH icon
2176
eHealth
EHTH
$43.9M
$1K ﹤0.01%
10
-519
-98% -$46.8K
SWBI icon
2177
Smith & Wesson
SWBI
$637M
$1K ﹤0.01%
260
-121,083
-100% -$730K
THS
2178
DELISTED
Treehouse Foods
THS
$1K ﹤0.01%
17
-2,906
-99% -$159K
VRDN icon
2179
Viridian Therapeutics
VRDN
$2.67B
$1K ﹤0.01%
67
-66
-50% -$1.46K
WSG
2180
DELISTED
Wanda Sports Group Company Limited American Depositary Shares
WSG
$1K ﹤0.01%
+348
New +$1.57K
ABEO icon
2181
Abeona Therapeutics
ABEO
$413M
-1,640
Closed -$196K
ACIU icon
2182
AC Immune
ACIU
$240M
-10,397
Closed -$58K
ACIW icon
2183
ACI Worldwide
ACIW
$5.46B
-48,081
Closed -$1.65M
ACLS icon
2184
Axcelis
ACLS
$4.31B
-24,381
Closed -$367K
ADEA icon
2185
Adeia
ADEA
$3.11B
-196,541
Closed -$1.07M
ADT icon
2186
ADT
ADT
$5.58B
-5,353
Closed -$33K
ADTN icon
2187
Adtran
ADTN
$616M
-33,368
Closed -$509K
AGEN
2188
Agenus
AGEN
$290M
-1,070
Closed -$63K
AKAM icon
2189
Akamai
AKAM
$16.1B
-8,120
Closed -$651K
AKBA icon
2190
Akebia Therapeutics
AKBA
$252M
-61,000
Closed -$295K
ALB icon
2191
Albemarle
ALB
$15.5B
-29,429
Closed -$2.07M
ALDX icon
2192
Aldeyra Therapeutics
ALDX
$93.5M
-5,072
Closed -$30K
ALEX
2193
DELISTED
Alexander & Baldwin
ALEX
-24,313
Closed -$562K
ALG icon
2194
Alamo Group
ALG
$2.05B
-3,377
Closed -$337K
AMED
2195
DELISTED
Amedisys
AMED
-11,696
Closed -$1.42M
AMH icon
2196
American Homes 4 Rent
AMH
$12.5B
-24,372
Closed -$592K
AMPY icon
2197
Amplify Energy
AMPY
$166M
-23,442
Closed -$138K
AMRN
2198
Amarin Corp
AMRN
$303M
-3,328
Closed -$1.29M
AMR icon
2199
Alpha Metallurgical Resources
AMR
$1.93B
-1,042
Closed -$54K
AMSC icon
2200
American Superconductor
AMSC
$1.59B
-15,910
Closed -$148K

Similar funds

Cubist Systematic Strategies's Q3 2019 Portfolio in Review

As of Q3 2019, Cubist Systematic Strategies held 2,696 positions worth $5.03B, down 7.6% from $5.45B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $287M in Q3 2019, closing 507 positions and reducing 1,045 holdings. Its most notable exit was VMware, Inc, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Cubist Systematic Strategies opened a new position in Blackstone worth $8.05M.

  • Cubist Systematic Strategies's largest Q3 2019 buy was Blackstone: 164,815 shares worth $8.05M.
  • Cubist Systematic Strategies added most to Elevance Health in Q3 2019, an estimated $36.6M increase.
  • Cubist Systematic Strategies's biggest Q3 2019 reduction was CVS Health, cutting an estimated $32.4M.
  • Cubist Systematic Strategies fully exited VMware, Inc in Q3 2019, selling an estimated $13.1M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.1% of its $5.03B portfolio in Q3 2019.
  • Cubist Systematic Strategies opened 268 new positions and closed 507 in Q3 2019.
  • Cubist Systematic Strategies's portfolio value fell 7.6% quarter-over-quarter to $5.03B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.